MediPharm Labs Corp. (TSX:LABS) is looking for M&A. David Pidduck, Chief Executive Officer said, "Our team is focused on driving revenue, both organically and through selective opportunistic M&A activities. Concurrently, we are executing against several priorities to optimize the business and drive towards profitability and positive cash flow.

We are executing these plans while maintaining MediPharm's mid to long-term orientation and investments in the pharma opportunity".